Important Program For Covid Patients Closes, Leaving Many Stranded
Home Test to Treat program is closing April 16. Patients have limited options for testing and getting treatment with Paxlovid.
Stay updated with breaking news from Radx Tech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Home Test to Treat program is closing April 16. Patients have limited options for testing and getting treatment with Paxlovid.
(The Conversation is an independent and nonprofit source of news, analysis and commentary...
Detect™, Inc., a Connecticut-based health technology company, announced today that the National Institutes of Health (NIH) has selected the Detect™ Covid-19 Test to receive funding from the highly competitive Rapid Acceleration of Diagnostics Initiative (RADxSM).
The NIH RADx initiative announced today that it has issued contract awards totaling $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2, the virus that causes COVID-19. The home and point-of-care testing platforms target the need for high-performance, low-cost home tests and point-of-care tests that can potentially detect multiple respiratory infections.
The home and point-of-care testing platforms target the need for high-performance, low-cost home tests and point-of-care tests that can potentially detect multiple respiratory infections.